Summit Therapeutics (SMMT) Reports Q1 Loss of GBP0.09/Share

Summit Therapeutics (NASDAQ: SMMT) reported Q1 EPS of (GBP0.09), versus (GBP0.06) reported last year.

For earnings history and earnings-related data on Summit Therapeutics (SMMT) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BMO starts chip stocks coverage: Here are its preferred picks
• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance